title: Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema.
abstract: C1 inhibitor deficiency (hereditary angioedema [HAE]) is a rare disorder for which there is a lack of consensus concerning diagnosis, therapy, and management, particularly in Canada. European initiatives have driven the approach to managing HAE with 3 C1-INH Deficiency Workshops held every 2 years in Hungary starting in 1999, with the third Workshop having recently been held in May 2003. The European Contact Board has established a European HAE Registry that will hopefully advance our knowledge of this disorder. The Canadian Hereditary Angioedema Society/Société d'Angioédème Héréditaire du Canada organized a Canadian International Consensus Conference held in Toronto, Ontario, Canada, on October 24 to 26, 2003, to foster consensus between major European and North American HAE treatment centers. Papers were presented by investigators from Europe and North America, and this consensus algorithm approach was discussed. There is a paucity of double-blind placebo-controlled trials in the treatment of HAE, making levels of evidence to support the algorithm less than optimal. Enclosed is the consensus algorithm approach recommended for the diagnosis, therapy, and management of HAE and agreed to by the authors of this article. This document is only a consensus algorithm approach and requires validation. As such, participants agreed to make this a living 2003 algorithm (ie, a work in progress) and agreed to review its content at future international HAE meetings. The consensus, however, has strength in that it was arrived at by the meeting of patient-care providers along with patient group representatives and individual patients reviewing information available to date and reaching agreement on how to approach the diagnosis, therapy, and management of HAE circa 2003. Hopefully evidence to support approaches to the management of HAE will approach the level of meta-analysis of randomized controlled trials in the near future.
authors.affiliation: Department of Medicine and Paeditrics, University of Calgary, Calgary, Alberta T2N 2T8, Canada. tbowen@pol.net
authors.forename: Tom
authors.initials: T
authors.lastname: Bowen
authors.forename: Marco
authors.initials: M
authors.lastname: Cicardi
authors.forename: Henriette
authors.initials: H
authors.lastname: Farkas
authors.forename: Konrad
authors.initials: K
authors.lastname: Bork
authors.forename: Wolfhart
authors.initials: W
authors.lastname: Kreuz
authors.forename: Lorenza
authors.initials: L
authors.lastname: Zingale
authors.forename: Lilian
authors.initials: L
authors.lastname: Varga
authors.forename: Inmaculada
authors.initials: I
authors.lastname: Martinez-Saguer
authors.forename: Emel
authors.initials: E
authors.lastname: Aygören-Pürsün
authors.forename: Karen
authors.initials: K
authors.lastname: Binkley
authors.forename: Bruce
authors.initials: B
authors.lastname: Zuraw
authors.forename: Alvin
authors.initials: A
authors.lastname: Davis
authors.forename: Jacques
authors.initials: J
authors.lastname: Hebert
authors.forename: Bruce
authors.initials: B
authors.lastname: Ritchie
authors.forename: Jeanne
authors.initials: J
authors.lastname: Burnham
authors.forename: Anthony
authors.initials: A
authors.lastname: Castaldo
authors.forename: Alejandra
authors.initials: A
authors.lastname: Menendez
authors.forename: Istvan
authors.initials: I
authors.lastname: Nagy
authors.forename: George
authors.initials: G
authors.lastname: Harmat
authors.forename: Christoph
authors.initials: C
authors.lastname: Bucher
authors.forename: Gina
authors.initials: G
authors.lastname: Lacuesta
authors.forename: Andrew
authors.initials: A
authors.lastname: Issekutz
authors.forename: Richard
authors.initials: R
authors.lastname: Warrington
authors.forename: William
authors.initials: W
authors.lastname: Yang
authors.forename: John
authors.initials: J
authors.lastname: Dean
authors.forename: Amin
authors.initials: A
authors.lastname: Kanani
authors.forename: Donald
authors.initials: D
authors.lastname: Stark
authors.forename: Christine
authors.initials: C
authors.lastname: McCusker
authors.forename: Eric
authors.initials: E
authors.lastname: Wagner
authors.forename: Georges-Etienne
authors.initials: GE
authors.lastname: Rivard
authors.forename: Eric
authors.initials: E
authors.lastname: Leith
authors.forename: Ellie
authors.initials: E
authors.lastname: Tsai
authors.forename: Michael
authors.initials: M
authors.lastname: MacSween
authors.forename: John
authors.initials: J
authors.lastname: Lyanga
authors.forename: Bazir
authors.initials: B
authors.lastname: Serushago
authors.forename: Art
authors.initials: A
authors.lastname: Leznoff
authors.forename: Susan
authors.initials: S
authors.lastname: Waserman
authors.forename: Jean
authors.initials: J
authors.lastname: de Serres
mesh_terms: D000465:Algorithms; D000799:Angioedema / Q000175:diagnosis* / Q000628:therapy*; D002170:Canada; D005260:Female; D006801:Humans; D007391:International Cooperation